Navigation Links
Drug combination shrinks breast cancer metastases in brain
Date:12/17/2007

SAN ANTONIO, Texas--A combination of a "targeted" therapy and chemotherapy shrank metastatic brain tumors by at least 50 percent in one-fifth of patients with aggressive HER2-positive breast cancer, according to data presented by Dana-Farber Cancer Institute investigators at the San Antonio Breast Cancer Symposium.

Lapatinib (Tykerb) and capecitabine (Xeloda) were paired in an extension of a Phase 2 clinical trial in which lapatinib given alone shrank brain metastases significantly in six percent of 241 patients.

In the extension trial, capecitabine was added to lapatinib in 49 patients whose metastases -- cancerous colonies in the brain spread from their primary cancer -- had progressed while on treatment. With the combination therapy, brain metastases shrank by 20 percent or more in 18 patients (37 percent) and shrank by at least 50 percent in 10 patients (20 percent), reported Nancy Lin, MD, of Dana-Farber's Breast Oncology Center.

"Very few medications have shown activity in the treatment of brain metastases, particularly in HER-2-positive metastatic breast cancer patients," said Lin, who led the study with Eric Winer, MD, director of the Dana-Farber Breast Oncology Center. "Therefore, these data are quite encouraging, and further studies are warranted."

The data (abstract 6076) will be presented on Sunday, Dec. 16 at 7 a.m. CT.

Lapatinib is an oral small-molecule drug from GlaxoSmithKline that is approved along with capecitabine for treating patients with advanced or metastatic breast cancer whose tumors are driven by the abnormal growth signal, HER-2, and who have already undergone therapy including trastuzumab (Herceptin), a taxane drug, and an anthracycline compound. Lapatinib, like trastuzumab, blocks the HER-2 signal.

Up to one-third of women with advanced, HER-2-positive breast cancer may develop metastases to the brain.

"Although radiation treatment is often effective, as women live long
'/>"/>

Contact: Bill Schaller
william_schaller@dfci.harvard.edu
617-632-5357
Dana-Farber Cancer Institute
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Promising drug combination may help those with ocular melanoma that has spread
2. Combination therapy reverses effects of portal hypertension in rats
3. Combination vaccines okay for infants, study shows
4. Antidepressants and painkillers - a dangerous combination
5. Intra-arterial combination chemotherapy induces long-term survival for hepatocellular carcinoma
6. U.S. Oncology Initiates Complete Phase Ib Trial of Brostallicin Combination Therapy in Advanced Solid Tumors
7. Drug combination might offer hope for patients deadly brain tumors
8. EpiCept to Present Preclinical Studies of EPC2407 in Combination With Anti-Angiogenic and Chemotherpeutic Agents at the AACR-NCI-EORTC International Conference
9. Combination targets: some drugs may work best when they work together
10. MAP Pharmaceuticals Initiates Phase 2a Clinical Trial of Combination Therapy in Adult Patients with Asthma
11. Quality Control: Nissan Quest to Feature micronAir(R) Combination Cabin Air Filters
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... Cubit Labs is pleased to announce YOUnify for ... , The popular cross platform contact sharing app first ... gleaning a solid 5 star rating in BlackBerry World ... been so easy and I highly recommend this for ... CrackBerry.com, View full App review here: http://crackberry.com/younify-blackberry-10? ...
(Date:9/23/2014)... Today Bibliomotion celebrates the ... Life to Work: A Guide for Leaders and ... book, Brower proves that organizations accomplish the best results ... informal cultural practices that help employees integrate and navigate ... that the investment will pay significant dividends in employee ...
(Date:9/23/2014)... 23, 2014 "Bee Towers” was featured on ... and features the latest technology gadgets and services available to ... conducted the tech review and shared with viewers ... fatigue. , Tablet sales rates in the United States continue ... Americans now own a tablet. , For consumers who ...
(Date:9/23/2014)... (PRWEB) September 23, 2014 According to ... Tough Mudder team just completed the Pittsburg 2014 ... course event that helps fund the wounded warrior project. ... Mudder team member, the ”Tough Mudder is an endurance ... course. Designed and created by British Special Forces to ...
(Date:9/23/2014)... PA (PRWEB) September 23, 2014 Rinovum ... home-use conception assistance device on the market cleared by ... in stores and online at http://www.storkotc.com . , ... dream of having a baby is delayed by infertility1 ... first step to optimize their chances to conceive. ...
Breaking Medicine News(10 mins):Health News:YOUnify for Android is Now Available in the Google Play Store 2Health News:Tracy Brower ‘Brings Work to Life’ in Her New Book, Published By Bibliomotion 2Health News:Tracy Brower ‘Brings Work to Life’ in Her New Book, Published By Bibliomotion 3Health News:Tracy Brower ‘Brings Work to Life’ in Her New Book, Published By Bibliomotion 4Health News:Tracy Brower ‘Brings Work to Life’ in Her New Book, Published By Bibliomotion 5Health News:“Bee Towers”, a Floor Standing Tablet Holder by XAR Motion, was Featured on NewsWatch, a National Television Show, This Month 2Health News:First-Ever Conception Assistance Device FDA-Cleared for Home Use Launches U.S. OTC Sales -- The Stork® OTC Delivers Hope to Millions Struggling to Conceive A Child 2Health News:First-Ever Conception Assistance Device FDA-Cleared for Home Use Launches U.S. OTC Sales -- The Stork® OTC Delivers Hope to Millions Struggling to Conceive A Child 3Health News:First-Ever Conception Assistance Device FDA-Cleared for Home Use Launches U.S. OTC Sales -- The Stork® OTC Delivers Hope to Millions Struggling to Conceive A Child 4
... International Retail Expansion, With Near Term Focus on Top ... ExtensionIRVINE, Calif., Jan. 21 University Medical ... and efficacy-based skin and beauty care products sold at ... U.S., announced today that it has appointed Tom Roche ...
... following statement can be attributed to Michael J. ... consistently said two things: We are not inherently ... we have urged public policy makers to think ... without conditions, because without conditions the merger would ...
... 21 Omnicell, Inc. (Nasdaq: OMCL ), a leading provider ... 29 to discuss the Company,s fourth quarter 2008 financial results. , ... webcast, ... Who: Randall Lipps, chairman, president and chief executive officer, ...
... (Nasdaq: IDXX ), has scheduled the release of ... January 30, at approximately 7:00 a.m. (eastern). The Company will ... on that day. Individuals can access a live Webcast of ... site, www.idexx.com . An archived edition of the call ...
... Carolina researchers say it could detect virus that can ... -- A new urine test that can detect a ... to better diagnosis and treatment of patients with polyomavirus ... patients. , Polyomaviruses are harmless to healthy adults ...
... -- Schizophrenia may blur the boundary between internal and ... involved in self-reflection, and thus causing an exaggerated focus ... study has found. , The traditional view of ... that characterize the disease are caused by disconnections among ...
Cached Medicine News:Health News:University Medical Pharmaceuticals Appoints Tom Roche as Senior Vice President, Global Sales and Marketing 2Health News:University Medical Pharmaceuticals Appoints Tom Roche as Senior Vice President, Global Sales and Marketing 3Health News:Capital Blue Cross Issues Statement on Withdrawal of Merger 2Health News:Omnicell to Release Fourth Quarter 2008 Earnings Results on January 29 2Health News:New Test May Help Kidney Transplant Patients 2Health News:Altered brain activity in schizophrenia may cause exaggerated focus on self 2Health News:Altered brain activity in schizophrenia may cause exaggerated focus on self 3
(Date:9/22/2014)... 2014 ... eTMF im Jahr 2015 verdoppeln werden ... klinischen Versuchsreihen, die zunehmenden Anforderungen der Gesundheitsbehörden ... mit Informationen über ihre Versuchsreihen (Trial Master ... Die bisher größte TMF-Umfrage in der ...
(Date:9/22/2014)... 22, 2014 Levi & Korsinsky is investigating ... "the Company") (NasdaqGS: SIAL ) for possible ... law in connection with the sale of the Company ... to learn more about the investigation: http://zlkdocs.com/SIAL-Info-Request-Form_ma-2199 , ... to you. Under the terms of the ...
(Date:9/22/2014)... Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR ... $200 million of its common stock in an underwritten ... Merrill Lynch are acting as joint book-running managers for ... option to purchase additional shares of its common stock. ... offering are being sold by Avanir.  The offering is ...
Breaking Medicine Technology:Branchenweite Umfrage zeigt, dass sich Fernzugriffe auf eTMF im Jahr 2015 verdoppeln werden 2Branchenweite Umfrage zeigt, dass sich Fernzugriffe auf eTMF im Jahr 2015 verdoppeln werden 3Branchenweite Umfrage zeigt, dass sich Fernzugriffe auf eTMF im Jahr 2015 verdoppeln werden 4Branchenweite Umfrage zeigt, dass sich Fernzugriffe auf eTMF im Jahr 2015 verdoppeln werden 5SIGMA-ALDRICH INVESTOR ALERT: Levi & Korsinsky, LLP Investigates the Board of Directors of Sigma-Aldrich Corporation In Connection with the Sale of the Company to Merck -- SIAL 2Avanir Pharmaceuticals Announces Proposed Public Offering of Common Stock 2Avanir Pharmaceuticals Announces Proposed Public Offering of Common Stock 3
... MELVILLE, N.Y., Nov. 28, 2011  Henry Schein, Inc. ... of health care products and services to office-based ... Complete™ program, a new integrated comprehensive solution that ... for the successful implementation of dental sleep medicine ...
... Medical Incorporated (OTCBB: ONCS), a biotechnology company developing ... cancer and other solid tumor cancers, today announced ... presenting at the 15th Annual Biotech and Specialty ... (Logo: http://photos.prnewswire.com/prnh/20110314/MM64943LOGO ) ...
Cached Medicine Technology:Patients Can Now Visit Their Dentist for Treatment and Monitoring of Sleep Apnea 2Patients Can Now Visit Their Dentist for Treatment and Monitoring of Sleep Apnea 3Patients Can Now Visit Their Dentist for Treatment and Monitoring of Sleep Apnea 4Patients Can Now Visit Their Dentist for Treatment and Monitoring of Sleep Apnea 5OncoSec to Present at 15th Annual Biotech and Specialty Pharmaceuticals Conference 2
... The UrinQuick Urine Chemistry Analyzer is ... analysis of urine test strips. The UrinQuick ... for QuickVue UrinChek 10+ SG and QuickVue ... analyzes the urine test strips by reflectance ...
... a qualitative assay for rapid detection of Strep ... Strep A test excels at detection of Strep ... colonization samples. This CLIA Waived test uses a ... Strep A leaves little chance for misdiagnosis, minimizing ...
The NOW Flu A test is the most frequently adopted rapid flu test on the market today. Testing could not be easier and the results are available in 15 minutes. Now you can focus on the results and tre...
...
Medicine Products: